Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

11.670 -

+0.250 (+2.19%)
Range 11.120 - 11.960   (7.55%)
Open 11.430
Previous Close 11.420
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 8,600,633
Value 77,953,567
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events

About Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis